Genus plc (LON:GNS - Get Free Report) insider Jorgen Kokke sold 3,450 shares of Genus stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of GBX 2,332, for a total transaction of £80,454.
Genus Trading Down 0.2%
LON:GNS opened at GBX 2,315 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The stock has a market capitalization of £1.52 billion, a PE ratio of -37,338.71, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The firm's 50 day moving average is GBX 2,543.64 and its 200 day moving average is GBX 2,149.43. Genus plc has a 12 month low of GBX 1,424 and a 12 month high of GBX 3,228.80.
Genus (LON:GNS - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. Sell-side analysts expect that Genus plc will post 70.9644323 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on GNS. Shore Capital reissued a "buy" rating and set a GBX 2,900 target price on shares of Genus in a report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Genus from GBX 2,550 to GBX 2,900 and gave the company a "buy" rating in a research report on Monday, September 15th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of GBX 2,900.
Check Out Our Latest Research Report on GNS
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
